ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
SoftBank returns to back synthetic biology firm Zymergen in a $400M series C round
December 26, 2018Zymergen has raised over $400 million in a series C funding round, which it says will help double the capacity of its synthetic biology contract manufacturing platform..... -
Zymergen announces $400M in Series C Funding
December 18, 2018To achieve these results, Zymergen uses artificial intelligence algorithms and robotic genomic “factories” to search the microbial genome, running tens of thousands of experiments to spot subtle signals of improvement
Pharma Sources Insight January 2025
